Related Experiment Video
Updated: Feb 8, 2026

Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
Depression, fatigue and neurocognitive deficits in chronic hepatitis C
Sern Wei Yeoh1, Alex C N Holmes2, Michael M Saling3,4,5
1Department of Gastroenterology, Eastern Health, 3 West, Building B, 8 Arnold St, Box Hill, VIC, 3128, Australia. syeoh58@hotmail.com.
Insights
Chronic hepatitis C virus (HCV) infection causes brain changes leading to depression and fatigue, even in early stages. These neurological effects may persist despite viral clearance, requiring ongoing multidisciplinary care.
Area of Science:
- Neuroscience
- Hepatology
- Infectious Diseases
Background:
- Chronic hepatitis C virus (HCV) infection is linked to significant quality-of-life impairments, including depression, fatigue, and neurocognitive deficits.
- These symptoms are observed even in early-stage HCV infection, independent of hepatic inflammation, comorbidities, or encephalopathy.
- The persistence of these symptoms suggests underlying intracerebral neurobiological changes associated with HCV infection.
Purpose of the Study:
- To explore the potential intracerebral neurobiological mechanisms underlying depression, fatigue, and neurocognitive deficits in patients with chronic hepatitis C virus (HCV) infection.
- To investigate whether these neurobiological changes are reversible after HCV clearance with direct-acting antiviral medications.
- To highlight the need for multidisciplinary care and potential future therapies targeting brain changes in HCV patients.
Main Methods:
- The study reviews existing literature on the neurobiological effects of HCV infection.
- It examines the mechanisms by which HCV may affect the brain, including cytokine infiltration and direct viral effects.
- It discusses the impact of these changes on brain function and the persistence of symptoms post-treatment.
Main Results:
- HCV infection is associated with intracerebral changes, including upregulated inflammation, altered neurotransmitter levels, hormonal dysregulation, and neurotoxic substance release.
- These neurobiological alterations can lead to impaired neuronal function in brain regions controlling mood, emotion, motivation, and cognition.
- Direct-acting antiviral therapy, while effective for viral clearance, may not fully reverse these intracerebral changes, leading to persistent symptoms.
Conclusions:
- Intracerebral neurobiological changes are a key factor in the persistent depression, fatigue, and neurocognitive deficits seen in HCV patients.
- These changes may result from HCV's direct or indirect effects on the central nervous system.
- Multidisciplinary care and pharmacotherapy are crucial for managing these symptoms, with future therapies potentially targeting the underlying neurobiological alterations.
Abstract:
Patients with chronic hepatitis C virus (HCV) infection experience a range of symptoms including depression, fatigue and neurocognitive deficits, impairing quality of life. Depression, in particular, may be reactive to increased psychosocial stress, and the physical symptoms of advanced HCV or associated comorbidities. However, even patients at an early stage of HCV infection, with minimal hepatic inflammation or comorbidities, report more depressive symptoms and fatigue than the general population. Similarly, specific neurocognitive deficits occur in early stage HCV infection and are independent of the presence of depression or encephalopathy. Therefore, intracerebral neurobiological changes associated with HCV may potentially explain these symptoms. These changes may arise from infiltration of the brain by peripherally induced cytokines, as well as direct neuropathic effects of HCV viral particles penetrating the blood-brain barrier. These phenomena parallel those reported in human immunodeficiency virus (HIV) infection. HCV-associated intracerebral changes include upregulated inflammatory responses, altered neurotransmitter levels, hormonal dysregulation, and release of neurotoxic substances. These may subsequently lead to abnormal neuronal conduction and function in areas of the brain governing affective responses, emotional processing, motivation, attention and concentration. Although direct-acting antiviral medications lead to high rates of HCV clearance, intracerebral changes may not be subsequently reversed and symptoms of depression, fatigue and neurocognitive deficits may persist. There is an ongoing role for multidisciplinary care and pharmacotherapy to manage these symptoms in HCV patients. Furthermore, there may be opportunities for future therapies to specifically target and ameliorate HCV-associated intracerebral changes.
More Related Videos
Related Concept Videos
Fatigue
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Depression: Overview

